281 related articles for article (PubMed ID: 24922069)
1. Platelet activation and anti-phospholipid antibodies collaborate in the activation of the complement system on platelets in systemic lupus erythematosus.
Lood C; Tydén H; Gullstrand B; Sturfelt G; Jönsen A; Truedsson L; Bengtsson AA
PLoS One; 2014; 9(6):e99386. PubMed ID: 24922069
[TBL] [Abstract][Full Text] [Related]
2. Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus--a possible link to venous thrombosis?
Lood C; Eriksson S; Gullstrand B; Jönsen A; Sturfelt G; Truedsson L; Bengtsson AA
Lupus; 2012 Nov; 21(13):1423-32. PubMed ID: 22878256
[TBL] [Abstract][Full Text] [Related]
3. Serum complement activation on heterologous platelets is associated with arterial thrombosis in patients with systemic lupus erythematosus and antiphospholipid antibodies.
Peerschke EI; Yin W; Alpert DR; Roubey RA; Salmon JE; Ghebrehiwet B
Lupus; 2009 May; 18(6):530-8. PubMed ID: 19395455
[TBL] [Abstract][Full Text] [Related]
4. Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus.
Svenungsson E; Gustafsson JT; Grosso G; Rossides M; Gunnarsson I; Jensen-Urstad K; Larsson A; Ekdahl KN; Nilsson B; Bengtsson AA; Lood C
Rheumatology (Oxford); 2020 Nov; 59(11):3264-3274. PubMed ID: 32259250
[TBL] [Abstract][Full Text] [Related]
5. Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid Syndrome.
Lonati PA; Scavone M; Gerosa M; Borghi MO; Pregnolato F; Curreli D; Podda G; Femia EA; Barcellini W; Cattaneo M; Tedesco F; Meroni PL
Front Immunol; 2019; 10():773. PubMed ID: 31031764
[TBL] [Abstract][Full Text] [Related]
6. Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL).
Savelli SL; Roubey RAS; Kitzmiller KJ; Zhou D; Nagaraja HN; Mulvihill E; Barbar-Smiley F; Ardoin SP; Wu YL; Yu CY
Front Immunol; 2019; 10():885. PubMed ID: 31134052
[TBL] [Abstract][Full Text] [Related]
7. Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis.
Cohen D; Koopmans M; Kremer Hovinga IC; Berger SP; Roos van Groningen M; Steup-Beekman GM; de Heer E; Bruijn JA; Bajema IM
Arthritis Rheum; 2008 Aug; 58(8):2460-9. PubMed ID: 18668574
[TBL] [Abstract][Full Text] [Related]
8. Potential Roles of Antiphospholipid Antibodies in Generating Platelet-C4d in Systemic Lupus Erythematosus.
Liu CC; Schofield T; Tang A; Manzi S; Ahearn JM
Antibodies (Basel); 2017 Jul; 6(3):. PubMed ID: 31548524
[TBL] [Abstract][Full Text] [Related]
9. Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus.
Lood C; Tydén H; Gullstrand B; Nielsen CT; Heegaard NH; Linge P; Jönsen A; Hesselstrand R; Kahn R; Bengtsson AA
Rheumatology (Oxford); 2017 Mar; 56(3):408-416. PubMed ID: 28031442
[TBL] [Abstract][Full Text] [Related]
10. Relation of platelet C4d with all-cause mortality and ischemic stroke in patients with systemic lupus erythematosus.
Kao AH; McBurney CA; Sattar A; Lertratanakul A; Wilson NL; Rutman S; Paul B; Navratil JS; Scioscia A; Ahearn JM; Manzi S
Transl Stroke Res; 2014 Aug; 5(4):510-8. PubMed ID: 24323718
[TBL] [Abstract][Full Text] [Related]
11. Platelet C4d is highly specific for systemic lupus erythematosus.
Navratil JS; Manzi S; Kao AH; Krishnaswami S; Liu CC; Ruffing MJ; Shaw PS; Nilson AC; Dryden ER; Johnson JJ; Ahearn JM
Arthritis Rheum; 2006 Feb; 54(2):670-4. PubMed ID: 16447243
[TBL] [Abstract][Full Text] [Related]
12. In systemic lupus erythematosus anti-dsDNA antibodies can promote thrombosis through direct platelet activation.
Andrianova IA; Ponomareva AA; Mordakhanova ER; Le Minh G; Daminova AG; Nevzorova TA; Rauova L; Litvinov RI; Weisel JW
J Autoimmun; 2020 Feb; 107():102355. PubMed ID: 31732191
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine, antiphospholipid antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
Martínez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Rueda M; Aguirre C
Lupus; 2004; 13(12):927-33. PubMed ID: 15645748
[TBL] [Abstract][Full Text] [Related]
14. Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology-Classified Systemic Lupus Erythematosus.
Ramsey-Goldman R; Alexander RV; Massarotti EM; Wallace DJ; Narain S; Arriens C; Collins CE; Saxena A; Putterman C; Kalunian KC; O'Malley T; Dervieux T; Weinstein A
Arthritis Rheumatol; 2020 Jan; 72(1):78-88. PubMed ID: 31469249
[TBL] [Abstract][Full Text] [Related]
15. Platelet bound complement split product (PC4d) is a marker of platelet activation and arterial vascular events in Systemic Lupus Erythematosus.
Gartshteyn Y; Mor A; Shimbo D; Khalili L; Kapoor T; Geraldino-Pardilla L; Alexander RV; Conklin J; Dervieux T; Askanase AD
Clin Immunol; 2021 Jul; 228():108755. PubMed ID: 33984497
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of soluble CD40 ligand are associated with antiphospholipid antibodies in patients with systemic lupus erythematosus.
Kim KJ; Baek IW; Yoon CH; Kim WU; Cho CS
Clin Exp Rheumatol; 2017; 35(5):823-830. PubMed ID: 28421990
[TBL] [Abstract][Full Text] [Related]
17. Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies.
Kim MY; Guerra MM; Kaplowitz E; Laskin CA; Petri M; Branch DW; Lockshin MD; Sammaritano LR; Merrill JT; Porter TF; Sawitzke A; Lynch AM; Buyon JP; Salmon JE
Ann Rheum Dis; 2018 Apr; 77(4):549-555. PubMed ID: 29371202
[TBL] [Abstract][Full Text] [Related]
18. Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus.
Kalunian KC; Chatham WW; Massarotti EM; Reyes-Thomas J; Harris C; Furie RA; Chitkara P; Putterman C; Gross RL; Somers EC; Kirou KA; Ramsey-Goldman R; Hsieh C; Buyon JP; Dervieux T; Weinstein A
Arthritis Rheum; 2012 Dec; 64(12):4040-7. PubMed ID: 22932861
[TBL] [Abstract][Full Text] [Related]
19. Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss.
Cohen D; Buurma A; Goemaere NN; Girardi G; le Cessie S; Scherjon S; Bloemenkamp KW; de Heer E; Bruijn JA; Bajema IM
J Pathol; 2011 Dec; 225(4):502-11. PubMed ID: 21688269
[TBL] [Abstract][Full Text] [Related]
20. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]